Food, drugs, devices › Jubilant Cadista Pharmaceuticals, Inc.
Drug recall: Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadista Pharmaceuticals, In
FDA enforcement event 87342 is a drug recall by Jubilant Cadista Pharmaceuticals, Inc. of Salisbury, MD, initiated 19 Feb 2021 and classified Class III, with 1 product record.
FDA defines Class III as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. 21% of the 299 drug enforcement events initiated in 2021 carry the same class.
Status: Terminated, terminated 15 Nov 2022. Initiation: voluntary: firm initiated. Jubilant Cadista Pharmaceuticals, Inc. has 25 enforcement events on this register, with a median of 1 product record per event.
Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.
Recalling firm
Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD.
Reason for recall
"Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card."
Distribution
"USA nationwide, including Puerto Rico."
Product records
| Recall number | Product | Quantity | Class | Status | Report date |
|---|---|---|---|---|---|
| D-0298-2021 | Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-001-03 | 635,400 cartons | Class III | Terminated | 10 Mar 2021 |
Context
Other enforcement events for Jubilant Cadista Pharmaceuticals, Inc.
All 25 events for Jubilant Cadista Pharmaceuticals, Inc.
Questions and answers
Why was this drug recalled?
FDA's record gives the reason for recall as: "Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card."
What does Class III mean?
FDA classifies recalls by relative degree of health hazard. Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
Where was the product distributed?
FDA's distribution pattern field reads: "USA nationwide, including Puerto Rico."
Is the recall still ongoing?
FDA lists the status as Terminated; the termination date is 15 Nov 2022. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.
Where does this data come from?
openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.
Provenance
Source: openFDA drug enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.